4//SEC Filing
Juda Scott 4
Accession 0001213900-24-106915
CIK 0001711754other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:00 PM ET
Size
5.3 KB
Accession
0001213900-24-106915
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Juda Scott
Director
Transactions
- Award
Option (right to buy)
2024-12-05+32,500→ 32,500 totalExercise: $5.05Exp: 2034-12-04→ Common Stock (32,500 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. The option will become 100% vested and exercisable on December 5, 2026, the two-year anniversary of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767084
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:00 PM ET
- Size
- 5.3 KB